Skip to content
Breathing, swallowing or vision problems: call the emergency services (15 or 112 in France).

Frown lines Botox gone wrong: possible problems and what to do

After an injection between the eyebrows, the eyelid may droop, an eyebrow may drop or rise at the tail, and the two sides may look uneven. These effects are known and temporary. This page presents them, lists the signs that should prompt you to see a doctor and links to the detailed page for each one.

Frown lines, the vertical creases between the eyebrows, are the area most often treated with botulinum toxin. They are surrounded by sensitive structures: the eyebrows above, the eyelids just below. Possible problems after an injection here therefore mainly affect these neighbours. This page is part of our SOS guide after a botulinum toxin injection, organised area by area.

What problems can follow a frown line injection?

Problems linked to frown lines

The frown line area has no problem page of its own: possible effects show up on the eyebrows or the eyelids, and each one has its page in the area concerned. They are the drooping eyelid, the drooping eyebrow, the eyebrow raised at the tail (Mephisto sign, or "Spock brow") and uneven eyebrows.

The labels describe these effects. After treatment of frown lines with a type A toxin, a drooping eyelid and headache are common, the Mephisto sign and eyelid swelling uncommon1. In trials that treated both frown lines and the forehead, a drooping eyelid appeared a median of 9 days after treatment1. Another product describes, as uncommon, a drooping eyelid or eyebrow, facial asymmetry and a feeling of heaviness in the eyelids or eyebrows3. For the short-acting botulinum toxin (serotype E), the label reports a drooping eyelid in 0.17% of patients, a drooping eyebrow in 0.13% and a Mephisto sign in 0.04%2. These frequencies come from different trials and cannot be compared with one another.

Which signs mean you should see a doctor quickly?

A drooping eyelid sometimes gets in the way of your vision, particularly in the evening or when driving: the short-acting toxin label notes a risk of drooping eyelid and visual disturbance that could affect driving2. If your vision is impaired, blurred or double, see a doctor promptly3. Any difficulty swallowing, speaking or breathing means calling emergency services (15 or 112 in France, or your local emergency number): these are the rare signs of the toxin spreading away from the injection site2.

If possible, contact the doctor who performed the injection first, noting the date of the injection and the day the problem appeared.

Why are frown lines injected?

The crease between the eyebrows is formed by two small muscles, the corrugators, and by the procerus muscle, at the root of the nose: this is where the injections are given2. The labels ask doctors to avoid the area near the muscle that lifts the eyelid and, for the short-acting toxin, to place injections in the outer part of the corrugator at least 1 cm above the bony rim of the eye socket2. In France, this is the only area approved for both type A toxins and the short-acting toxin1,2. As of 9 October 2026, the short-acting toxin is approved in the European Union (since 15 July 2026) and in Canada (since 22 June 2026)4,5. To understand how and why frown lines are treated, see the page for this area in our atlas of treatment areas.

This area is often treated together with the forehead: if your problem is located there instead, see the page on the forehead after an injection. If it is mainly the eyelid that is affected, the page on drooping or puffy eyelids covers these situations.

Key points

  • Possible effects mainly affect the eyelids and eyebrows1,2.
  • In trials of one type A toxin, a drooping eyelid appeared a median of 9 days after treatment1.
  • These effects are temporary: they follow the duration of the product’s effect.
  • Problem with your vision: see a doctor promptly; difficulty swallowing, speaking or breathing: call emergency services.

Frequently asked questions

  • Why does the eyelid droop after a frown line injection?

    Because the toxin can spread to the muscle that lifts the upper eyelid, located just below the treated area. The labels advise avoiding injections close to this muscle1,2. With a type A toxin, a drooping eyelid is a common effect after treatment of frown lines; in trials that also treated the forehead, it appeared a median of 9 days after the injection1. It disappears as the effect of the toxin wears off.

  • Does the problem last for a shorter time with the short-acting toxin?

    The duration of an unwanted effect follows that of the product. For the short-acting toxin, the only one approved for this area besides type A toxins, the effect generally lasts 2 to 3 weeks2. For a type A toxin, the effect has been shown for up to 4 months1. These durations describe the products, not a preference: the choice is made with your doctor, depending on what you are looking for.

Sources

  1. 1.SmPC of a type A botulinum toxin approved for aesthetic use in France (BDPM, CIS 68150775) (opens in a new tab) — French public medicines database (BDPM)
  2. 2.Summary of product characteristics of the serotype E botulinum toxin approved in the European Union (EPAR annex I) (opens in a new tab) — European Commission (Union Register of medicinal products)
  3. 3.SmPC of a type A botulinum toxin approved for aesthetic use in France (BDPM, CIS 61592762) (opens in a new tab) — French public medicines database (BDPM)
  4. 4.European public assessment report (EPAR) of the serotype E botulinum toxin (opens in a new tab) — European Commission (Union Register of medicinal products)
  5. 5.Canadian product monograph of the serotype E botulinum toxin (authorization date: 2026-06-22) (opens in a new tab) — Health Canada
Book an appointmentSOS after an injection